Patents by Inventor Gerald M. Anchin

Gerald M. Anchin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunoassay for creatine kinase-MB and creatine kinase-BB isoforms and reagents
    Patent number: 5382522
    Abstract: Methods and reagents for determining the lapse of time since an acute disease event, such as the occurrence of a myocardial infarction, are presented. A serum or plasma sample is assayed to determine the concentration of two different analytes selected from the group consisting of creatine kinase-MB species and creatine kinase-BB species. From these measurements, the time of the acute event can be more accurately determined. Novel antibodies, labeled and insolubilized derivatives of these antibodies, labeled proteins, and kits containing one or more of these reagents are also described.
    Type: Grant
    Filed: June 25, 1993
    Date of Patent: January 17, 1995
    Assignee: International Immunoassay Laboratories, Inc.
    Inventors: Vipin D. Shah, Shing-Erh Yen, Gerald M. Anchin
  • Creative kinase-MB immunoassay for myocardial infarction and reagents
    Patent number: 5382515
    Abstract: Methods and reagents for determining the lapse of time since an acute disease event, such as the occurrence of a myocardial infarction, are presented. A serum or plasma sample is assayed to determine the concentration of two different analytes selected from a group of creatine kinase-MB species. From these measurements, the time of the acute event can be more accurately determined. Novel antibodies, labeled and insolubilized derivatives of these antibodies, labeled proteins, and kits containing one or more of these reagents are also described.
    Type: Grant
    Filed: June 25, 1993
    Date of Patent: January 17, 1995
    Assignee: International Immunoassay Laboratories, Inc.
    Inventors: Vipin D. Shah, Shing-Erh Yen, Gerald M. Anchin
  • Myocardial infarction immunoassay
    Patent number: 5202234
    Abstract: Methods and reagents for determining the lapse of time since an acute disease event, such as the occurrence of a myocardial infarction, are presented. A serum sample is assayed to determine the concentration of two analyte sets. From these measurements, the time of the acute event can be more accurately determined. Novel antibodies, labeled and insolubilized derivatives of these antibodies, labeled proteins, and kits containing one or more of these reagents are also described.
    Type: Grant
    Filed: January 23, 1989
    Date of Patent: April 13, 1993
    Assignee: Internationl Immunoassay Laboratories, Inc.
    Inventors: Vipin D. Shah, Shing-Erh Yen, Gerald M. Anchin
  • CK-MM myocardial infarction immunoassay
    Patent number: 4900662
    Abstract: Methods and reagents for early detection of myocardial infarction determine the level of CK-MM.sub.A and the level of the combined CK-MM.sub.A and CK-MM.sub.B in a serum sample. From these measurements, the time of the acute phase can be more accurately determined. Novel anti-(CK-MM.sub.A) antibodies, anti-(CK-MM.sub.B) antibodies, anti-(CK-MM.sub.(A+B)) antibodies, labeled and insolubilized derivatives of these antibodies, labeled CK-MM isoforms, and kits containing one or more of these reagents are also described.
    Type: Grant
    Filed: July 21, 1987
    Date of Patent: February 13, 1990
    Assignee: International Immunoassay Laboratories, Inc.
    Inventors: Vipin D. Shah, Shing-Erh Yen, Gerald M. Anchin